The impact of sample processing on inflammatory markers in serum: Lessons learned

Area of Science:

• Biochemistry
• Immunology
• Biomarker Research

Background:

• Inflammatory cytokines are key biomarkers for various diseases, including bipolar disorder (BD).
• Biobanks are increasingly used for large-scale biomarker research, but sample handling can affect results.
• Standardized sample collection and processing are vital for reliable biomarker studies.

Purpose of the Study:

• To assess how sample handling, specifically pre-processing time, affects inflammatory cytokine concentrations in serum.
• To identify challenges in using pre-collected biobank samples for biomarker research.
• To investigate cytokine differences in bipolar disorder patients compared to controls.

Main Methods:

• Cytokine concentrations (IL-1β, IL-2, IL-6, IL-8, IL-10, TNFα, IFNγ) were measured in serum from 205 BD patients and 205 controls.
• Post-hoc analyses examined the influence of clinical variables and pre-processing time on cytokine levels.
• An experimental study assessed cytokine changes in serum and plasma from healthy volunteers processed at different time points.

Main Results:

• Significantly higher cytokine levels were observed in the bipolar disorder group.
• Cytokine levels and pre-processing times varied by recruitment site, with pre-processing time associated with several cytokines.
• Experimental validation confirmed that longer pre-processing times increased concentrations of most measured cytokines.

Conclusions:

• Delays in blood sample processing demonstrably alter inflammatory cytokine concentrations.
• Researchers must carefully evaluate sample collection and handling protocols when utilizing biobanked samples for biomarker studies.
• Standardizing pre-processing times is essential for accurate and reproducible biomarker research.